• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

optiscanbiomedical

7 medtech advances to improve diabetes treatment

January 10, 2020 By Sean Whooley

Medtech and pharmaceutical companies have made several important strides over the past year when it comes to improving diabetes treatment. Multiple treatments and technologies have cleared regulatory hurdles and are now hitting the market and making the process of living with diabetes that much more manageable. Several different styles of therapy and devices have come […]

Pages: Page 1 Page 2

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Technology Tagged With: dariohealth, FDA, Medtronic, Novo Nordisk, One Drop, optiscanbiomedical, popsdiabetescare, Senseonics, Tandem Diabetes Care, Valeritas Inc.

OptiScan raises $20m for bedside glucose monitoring system

March 20, 2019 By Sarah Faulkner

OptiScan Biomedical said today that it closed a $20 million Series E round to support the commercialization of its continuous monitoring system, the OptiScanner 5000, in the U.S. The company’s device is an automated bedside blood glucose monitor designed for use in the intensive care unit. The system can measure glucose values from a micro-sample […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: optiscanbiomedical

OptiScan CEO: Glucose monitor approval is biggest advancement for ICU care in 10 years

October 23, 2017 By Sarah Faulkner

OptiScan

Just last week, OptiScan Biomedical announced that its OptiScanner 5000 glucose monitoring system won 510(k) clearance for use in surgical intensive care units. The regulatory win was supported by eight rigorous clinical trials, CEO Peter Rule told Drug Delivery Business News, and represents a victory for a technology that the company hopes to expand into a platform system. […]

Filed Under: Diabetes, Featured, Food & Drug Administration (FDA), Hospital Care, Regulatory/Compliance Tagged With: optiscanbiomedical

OptiScan’s glucose monitoring system for the ICU wins 510(k) clearance

October 18, 2017 By Sarah Faulkner

OptiScan

OptiScan Biomedical said today that its OptiScanner 5000 glucose monitoring system won 510(k) clearance. The device is the first of its kind, providing physicians with trending and tracking information to manage their patients’ blood glucose levels in surgical intensive care units. The Hayward, Calif.-based company’s technology uses alarms to alert clinicians when patients are experiencing […]

Filed Under: Diabetes, Featured, Food & Drug Administration (FDA), Hospital Care, Regulatory/Compliance Tagged With: optiscanbiomedical

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS